Researchers might have found evidence that chronic fatigue syndrome is a real and legitimate neurological condition. A pilot study published today in the open access journal BMC Neurology reveals that patients with chronic fatigue syndrome (CFS) have a set of proteins in their spinal cord fluid that were not detected in healthy individuals. These proteins might give insight into the causes of CFS, and could be used as markers to diagnose patients with CFS.
James Baraniuk and Begona Casado, from Georgetown University in the US, and colleagues from other institutions in the US and Italy, studied the content of the spinal cord fluid, or cerebrospinal fluid, in CFS patients and healthy individuals. This fluid can be tested for the diagnosis of various neurological diseases and infections. The researchers identified 16 proteins that can be found in patients with CFS but not in healthy individuals. Five of these proteins are found in all CFS patients but none of the controls. They could be a biosignature for the disease, which could be used to diagnose it.
This is a pilot study, but Baraniuk et al. conclude that "this is the first predictive model of chronic fatigue syndrome to be based only on objective data". They add: "Given the controversy over whether CFS and its allied syndromes are legitimate medical conditions, our model provides initial objective evidence for the legitimacy of CSF as a distinct neurological disease."
Juliette Savin | EurekAlert!
A sudden drop in outdoor temperature increases the risk of respiratory infections
11.01.2017 | University of Gothenburg
Urbanization to convert 300,000 km2 of prime croplands
27.12.2016 | Mercator Research Institute on Global Commons and Climate Change (MCC) gGmbH
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).
Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...
10.01.2017 | Event News
09.01.2017 | Event News
05.01.2017 | Event News
18.01.2017 | Power and Electrical Engineering
18.01.2017 | Materials Sciences
18.01.2017 | Life Sciences